The CD45 transmembrane glycoprotein has been shown to be a protein phosphotyrosine phosphatase and to be important in signal transduction in T and B lymphocytes. We have employed gene targeting to create a strain of transgenic mice that completely lacks expression of all isoforms of CD45. The spleens from CD45-null mice contain approximately twice the number of B cells and one fifth the number of T cells found in normal controls. The increase in B cell numbers is due to the specific expansion of two B cell subpopulations that express high levels of immunoglobulin (IgM) staining. T cell development is significantly inhibited in CD45-null animals at two distinct stages. The efficiency of the development of CD4-CD8- thymocytes into CD4+ CD8+ thymocytes is reduced by twofold, subsequently the frequency of successful maturation of the double positive population into mature, single positive thymocytes is reduced by a further four- to fivefold. In addition, we demonstrate that CD45-null thymocytes are severely impaired in their apoptotic response to cross-linking signals via T cell receptor (TCR) in fetal thymic organ culture. In contrast, apoptosis can be induced normally in CD45-null thymocytes by non-TCR-mediated signals. Since both positive and negative selection require signals through the TCR complex, these findings suggest that CD45 is an important regulator of signal transduction via the TCR complex at multiple stages of T cell development. CD45 is absolutely required for the transmission of mitogenic signals via IgM and IgD. By contrast, CD45-null B cells proliferate as well as wild-type cells to CD40-mediated signals. The proliferation of B cells in response to CD38 cross-linking is significantly reduced but not abolished by the CD45-null mutation. We conclude that CD45 is not required at any stage during the generation of mature peripheral B cells, however its loss reveals a previously unrecognized role for CD45 in the regulation of certain subpopulations of B cells.
Skip Nav Destination
Article navigation
1 April 1996
Article|
April 01 1996
CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation.
K F Byth,
K F Byth
Department of Pathology, Cambridge University, United Kingdom.
Search for other works by this author on:
L A Conroy,
L A Conroy
Department of Pathology, Cambridge University, United Kingdom.
Search for other works by this author on:
S Howlett,
S Howlett
Department of Pathology, Cambridge University, United Kingdom.
Search for other works by this author on:
A J Smith,
A J Smith
Department of Pathology, Cambridge University, United Kingdom.
Search for other works by this author on:
J May,
J May
Department of Pathology, Cambridge University, United Kingdom.
Search for other works by this author on:
D R Alexander,
D R Alexander
Department of Pathology, Cambridge University, United Kingdom.
Search for other works by this author on:
N Holmes
N Holmes
Department of Pathology, Cambridge University, United Kingdom.
Search for other works by this author on:
K F Byth
,
L A Conroy
,
S Howlett
,
A J Smith
,
J May
,
D R Alexander
,
N Holmes
Department of Pathology, Cambridge University, United Kingdom.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1996) 183 (4): 1707–1718.
Citation
K F Byth, L A Conroy, S Howlett, A J Smith, J May, D R Alexander, N Holmes; CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation.. J Exp Med 1 April 1996; 183 (4): 1707–1718. doi: https://doi.org/10.1084/jem.183.4.1707
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement